Showing 28,901 - 28,920 results of 224,509 for search '(( a ((((larger decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a largest decrease ))', query time: 1.34s Refine Results
  1. 28901
  2. 28902
  3. 28903

    Supplementary Material for: Decreased Blood Flow after Sorafenib Administration Is an Imaging Biomarker to Predict Overall Survival in Patients with Advanced Hepatocellular Carcino... by Arizumi T. (3588833)

    Published 2014
    “…Sorafenib administration induces temporary inhibition of tumor growth and a decrease in arterial blood flow in a considerable number of hepatocellular carcinoma (HCC) patients. …”
  4. 28904

    Table_1_Red blood cells from patients with sitosterolemia exhibit impaired membrane lipid composition and distribution and decreased deformability.docx by Anne-Sophie Cloos (9082913)

    Published 2023
    “…<p>Sitosterolemia is a metabolic disorder leading to excessive accumulation of phytosterols. …”
  5. 28905

    Image_1_Red blood cells from patients with sitosterolemia exhibit impaired membrane lipid composition and distribution and decreased deformability.jpeg by Anne-Sophie Cloos (9082913)

    Published 2023
    “…<p>Sitosterolemia is a metabolic disorder leading to excessive accumulation of phytosterols. …”
  6. 28906
  7. 28907
  8. 28908
  9. 28909
  10. 28910

    IL-2 (but not IFN-γ or TNF) production by CD4+ T cells is decreased 72h following CLP in alcohol-fed animals. by Lindsay M. Margoles (2577001)

    Published 2016
    “…<p>Representative flow plot and summary data 72h following sepsis, demonstrating a trend toward decreased IL-2 production due to alcohol alone between sham groups which did not reach significance, but there was a significant decrease in IL-2 in alcohol septic animals compared with water septic (16.15±1.7% vs 26.7±1.74%, p = 0.004). …”
  11. 28911
  12. 28912

    Table_1_Tumor-Acidity Responsive Polymeric Nanoparticles for Targeting Delivery of Angiogenesis Inhibitor for Enhanced Antitumor Efficacy With Decreased Toxicity.docx by Xiufeng Cong (10361204)

    Published 2021
    “…Systemic administration of the anlotinib-loaded nanocarrier into mice bearing A549 and 4T1 subcutaneous tumor received a higher tumor growth suppression and metastasis inhibition without detectable side effects. …”
  13. 28913

    Table1_An Adverse Outcome Pathway for Decreased Lung Function Focusing on Mechanisms of Impaired Mucociliary Clearance Following Inhalation Exposure.docx by Karsta Luettich (6340385)

    Published 2021
    “…<p>Adverse outcome pathways (AOPs) help to organize available mechanistic information related to an adverse outcome into key events (KEs) spanning all organizational levels of a biological system(s). AOPs, therefore, aid in the biological understanding of a particular pathogenesis and also help with linking exposures to eventual toxic effects. …”
  14. 28914
  15. 28915

    Table_2_Tumor-Acidity Responsive Polymeric Nanoparticles for Targeting Delivery of Angiogenesis Inhibitor for Enhanced Antitumor Efficacy With Decreased Toxicity.docx by Xiufeng Cong (10361204)

    Published 2021
    “…Systemic administration of the anlotinib-loaded nanocarrier into mice bearing A549 and 4T1 subcutaneous tumor received a higher tumor growth suppression and metastasis inhibition without detectable side effects. …”
  16. 28916
  17. 28917
  18. 28918

    Estimated short- and long-term cumulative changes in CRC incidence and CRC mortality attributable to screening, diagnosis, and treatment decreases in 2020 and 2021. by Joachim Worthington (8394213)

    Published 2024
    “…Includes short-term decreases to incidence due to reductions in diagnoses, and long-term increases due to CRC which were not removed at screening at a precancerous stage.…”
  19. 28919
  20. 28920